ArticlePloS one2026
Association of VDR gene polymorphisms with prediabetes and Type 2 diabetes mellitus in a sample of the Iranian population.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a prevalent chronic disorder responsible for most diabetes cases. The role of vitamin D receptor (VDR) gene variants in T2DM susceptibility has been investigated previously; however, the results are contradictory, particularly among diverse ethnic groups. This study aimed to investigate the association between VDR gene polymorphisms and T2DM in a sample of the Iranian population.
methodsData from 976 participants of the phase 3 Iranian Multicenter Osteoporosis Study (IMOS) were analyzed. Five VDR polymorphisms (ApaI, TaqI, EcoRV, FokI, and BsmI) were genotyped and assessed among diabetic (DM), prediabetic (preDM), and healthy participants. We employed logistic regression models to evaluate the association of VDR polymorphisms with preDM and DM, accounting for potential confounding factors, including age, gender, body mass index (BMI), and vitamin D levels.
resultsThe multivariable logistic regression analysis indicated a significant relationship between the ApaI polymorphism (rs7975232) and the risk of developing preDM or DM. Specifically, individuals with the CC genotype exhibited a 66% increased likelihood of progressing to preDM or DM compared to those with the AA genotype [OR: 1.66 (1.07, 2.56)]. In examining the A dominant state, individuals carrying at least one A allele (AA or AC genotypes) were found to be 35% less likely to develop preDM or DM when compared to those with the CC genotype [OR: 0.65 (0.43, 0.97)]. No significant associations were identified for the other polymorphisms (TaqI, EcoRV, FokI, and BsmI).
conclusionThese findings indicate that the C allele of the ApaI polymorphism may be associated with an increased susceptibility to T2DM in this population, underscoring the VDR gene's role in T2DM risk and pointing to potential personalized prevention and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.